Non-surgical casting versus surgical reduction for children with severely displaced distal radial fractures (the CRAFFT Study): a multicentre, randomised, controlled non-inferiority trial and economic evaluation.

Este estudio ha sido identificado como potencialmente de alto impacto. La métrica de alto impacto de OE, basada en la inteligencia artificial, estima la influencia que puede tener un artículo integrando señales procedentes tanto de la revista en la que se publica como del contenido científico del propio artículo. Desarrollado mediante el procesamiento del lenguaje natural más avanzado, el modelo de Alto Impacto de OE predice con mayor precisión el futuro rendimiento de las citas de un estudio que el factor de impacto de la revista por sí solo. Esto permite reconocer antes las investigaciones clínicamente significativas y ayuda a los lectores a centrarse en los artículos con más probabilidades de configurar la práctica futura.

Resumen del estudio

750 children aged 4–10 years with severely displaced distal radial fractures were randomized to receive non-surgical casting or surgical reduction. The primary outcome of interest was upper limb function at 3 months, measured using the Patient Reported Outcomes Measurement Information System (PROMIS) Upper Extremity Score for Children. Secondary outcomes included pain, health-related quality of life, cosmetic appearance, complications, unplanned surgery, and health-care costs. Outcomes were assessed at 6 weeks and 3, 6, and 12 months. Overall, the results revealed that surgical reduction provided a small improvement in upper limb function at 3 months, and non-inferiority of casting was not established against the prespecified margin. However, functional differences were no longer evident at 6 or 12 months, while casting was associated with fewer early complications and substantially lower costs. These findings suggested that non-surgical casting could be considered as an initial treatment strategy for most children with severely displaced distal radial fractures.